MLH1 and gastric cancer: Another retrospective study from Japan including 285 GC patients showed that loss of the MMR-protein MLH1 was associated with chemoresistance and did not prolong recurrence-free survival of GC patients following neoadjuvant S−1/platinum-based chemotherapy (Hashimoto et al. 2019).